Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial (Q38212374)
Jump to navigation
Jump to search
scientific article published on 13 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial |
scientific article published on 13 May 2014 |
Statements
1 reference
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial (English)
1 reference
Sophie D Fosså
Nicholas J Vogelzang
Oliver Sartor
Robert Coleman
Sten Nilsson
Daniel Heinrich
Svein I Helle
Joe M O'Sullivan
Aleš Chodacki
John Logue
Anders Widmark
Dag Clement Johannessen
Nicholas D James
Arne Solberg
Isabel Syndikus
C Gillies O'Bryan-Tear
Minghua Shan
13 May 2014
1 reference